| Literature DB >> 29334428 |
Marco Paolino1, Margherita Brindisi1, Alessandra Vallone1, Stefania Butini1, Giuseppe Campiani1, Chiara Nannicini1, Germano Giuliani1, Maurizio Anzini1, Stefania Lamponi1, Gianluca Giorgi1, Diego Sbardella2, Davide M Ferraris3, Stefano Marini2, Massimo Coletta2, Ivana Palucci4, Mariachiara Minerva4, Giovanni Delogu4, Ilaria Pepponi5, Delia Goletti5, Andrea Cappelli1, Sandra Gemma1, Simone Brogi1.
Abstract
The enzyme Zmp1 is a zinc-containing peptidase that plays a critical role in the pathogenicity of Mycobacterium tuberculosis. Herein we describe the identification of a small set of Zmp1 inhibitors based on a novel 8-hydroxyquinoline-2-hydroxamate scaffold. Among the synthesized compounds, N-(benzyloxy)-8-hydroxyquinoline-2-carboxamide (1 c) was found to be the most potent Zmp1 inhibitor known to date, and its binding mode was analyzed both by kinetics studies and molecular modeling, identifying critical interactions of 1 c with the zinc ion and residues in the active site. The effect of 1 c on intracellular Mycobacterium survival was assayed in J774 murine macrophages infected with M. tuberculosis H37Rv or M. bovis BCG and human monocyte-derived macrophages infected with M. tuberculosis H37Rv. Cytotoxicity and genotoxicity were also assessed. Overall, inhibitor 1 c displays interesting in vitro antitubercular properties worthy of further investigation.Entities:
Keywords: 8-hydroxyquinoline-2-hydroxamate; Mycobacterium tuberculosis; QPLD; Zmp1; metalloprotease inhibitors
Mesh:
Substances:
Year: 2018 PMID: 29334428 DOI: 10.1002/cmdc.201700759
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466